AbbVie | ABBV - PE Price to Earnings

Stock Price
217.11
Daily Change
-8.55 -3.79%
Monthly
-1.39%
Yearly
13.23%
Q1 Forecast
216.14

AbbVie reported $110.26 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 110.26 91.85 Sep/2025
Abbott USD 30.71 14.41 Dec/2025
ALKERMES USD 14.9 1.11 Sep/2025
Amgen USD 9.49 3.02 Sep/2025
AstraZeneca USD 21.49 1.46 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Bristol-Myers Squibb USD 8.24 9.03 Sep/2025
Eisai JPY 26.16 4.7 Sep/2025
Eli Lilly USD 49.87 12.87 Sep/2025
Gilead Sciences USD 15.72 0.32 Sep/2025
GlaxoSmithKline GBP 11.44 6.82 Sep/2025
J&J USD 23.62 0.86 Dec/2025
Medtronic USD 21.44 0.62 Sep/2025
Merck USD 8.84 0.26 Sep/2025
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Novartis USD 15.74 0.15 Sep/2025
Pacira USD 29.24 6.15 Sep/2025
Perrigo USD 34.31 15.46 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
UCB EUR 35.22 3.9 Jun/2025
United Therapeutics USD 15.7 4.24 Sep/2025
Vertex Pharmaceuticals USD 23.93 3.88 Sep/2025
Zoetis USD 23.26 2.68 Sep/2025